Earnings Neutral 5

Smith & Nephew and AAON Signal Long-Term Growth in Q4 Earnings Reports

· 3 min read · Verified by 2 sources · By Finance Intelligence Brief Editorial
Share

Key Takeaways

  • Smith & Nephew and AAON both reported Q4 results that emphasize long-term margin expansion and revenue targets through 2026 and beyond.
  • While AAON faced a mixed quarter with flat revenue growth, Smith & Nephew's multi-year guidance suggests a structural turnaround in its orthopaedics and wound care segments.

Mentioned

Smith & Nephew company SNN AAON company AAON

Key Intelligence

Key Facts

  1. 1Smith & Nephew reported Q4 revenue of $1.46 billion, a 4.8% underlying increase.
  2. 2SNN set a long-term trading profit margin target of 22% by FY2028.
  3. 3AAON reported Q4 EPS of $0.57, beating analyst estimates by $0.01.
  4. 4AAON's total backlog stood at $514.5 million at the end of Q4, down from $522.6 million.
  5. 5AAON introduced FY26 revenue growth guidance of high-single to low-double digits.
Metric
Q4 Revenue $1.46B $306.6M
Revenue Growth (YoY) +4.8% (Underlying) +0.1%
FY25 Growth Outlook 4.3% - 5.3% Mid-to-High Single Digit
FY26 Growth Outlook 5%+ High-Single to Low-Double Digit

Analysis

The latest quarterly reports from Smith & Nephew and AAON highlight a significant shift in corporate strategy, moving away from short-term quarterly beats toward long-term structural efficiency and margin expansion. For Smith & Nephew (SNN), the global medical technology giant, the Q4 results underscore a steady recovery in its core orthopaedics and sports medicine businesses. The company reported Q4 revenue of $1.46 billion, representing a 4.8% underlying growth rate, which contributed to a full-year 2024 revenue of $5.83 billion. This performance is particularly notable as SNN continues to execute its multi-year turnaround plan, aimed at addressing historical supply chain inefficiencies and product availability issues that have previously hampered its orthopaedics division.

What caught the market's attention was not just the Q4 performance, but the aggressive long-term guidance provided by Smith & Nephew. The company introduced targets for FY26 and FY28 that signal a high degree of confidence in its operational leverage. By 2026, SNN expects underlying revenue growth of at least 5% and a trading profit margin of 20% or higher. Looking further out to 2028, the margin target expands to 22%. This trajectory suggests that the company is successfully pivoting from a period of restructuring to one of sustained profitability, driven by high-margin product launches in its Advanced Wound Management and Sports Medicine segments. Investors are likely to view these targets as a commitment to closing the valuation gap with peers like Stryker and Zimmer Biomet.

The company reported Q4 revenue of $1.46 billion, representing a 4.8% underlying growth rate, which contributed to a full-year 2024 revenue of $5.83 billion.

In the industrial sector, AAON reported a more nuanced Q4, characterized by mixed results that reflect broader trends in the HVAC and commercial cooling markets. While the company beat earnings estimates with an EPS of $0.57, its revenue growth was essentially flat year-over-year at $306.6 million. This stagnation in top-line growth was accompanied by a slight decrease in the company's backlog, which fell to $514.5 million from $522.6 million in the previous quarter. However, AAON’s management remains optimistic about the medium-term outlook, particularly as demand for high-efficiency cooling solutions in data centers and commercial retrofits continues to grow. The company’s introduction of an FY26 outlook—projecting high-single to low-double digit revenue growth—suggests that the current slowdown is viewed as a temporary digestion period rather than a structural decline.

What to Watch

The divergence between SNN’s steady growth and AAON’s flat revenue highlights the differing macro-environments for medical technology and industrial HVAC. SNN is benefiting from a post-pandemic normalization of elective surgeries and an aging global population, while AAON is navigating a more cyclical commercial construction market. Despite these differences, both companies are prioritizing margin health. AAON’s ability to beat EPS despite flat revenue indicates strong pricing power and cost control, a theme that is echoed in SNN’s focus on trading profit margins. For analysts, the key takeaway is the emphasis on 'quality of earnings' over raw volume, as both firms prepare for a more competitive 2025 and 2026.

Looking ahead, the primary risk for Smith & Nephew remains the execution of its orthopaedic recovery, particularly in the U.S. market where competition is fierce. For AAON, the focus will be on converting its substantial backlog into revenue and whether the projected acceleration in 2026 can materialize amidst fluctuating interest rates and construction starts. Both companies have set a high bar for themselves with multi-year targets, and the coming quarters will be a test of their ability to maintain operational discipline while chasing growth in their respective high-tech niches.

Timeline

Timeline

  1. FY24 Close

  2. FY25 Guidance

  3. FY26 Targets

  4. FY28 Strategic Goal

Related Stories

Earnings

Adobe Q2: $6.62B Revenue, $410 DCF Target — 40%+ Upside

Adobe’s Q2 FY26 beat estimates with $6.62B revenue, guidance raised to $26.55B. A DCF model suggests a $410 target price, implying over 40% upside. Margin resilience and AI ARR growth counterbalance governance risks.

Earnings

Monash IVF Slashes Profit Outlook by 15% as Australian Cycles Decline

Monash IVF cuts FY26 profit guidance to $17-18M, citing a 4.7% drop in ART cycles, while fending off a $0.90 takeover bid. The financial story now hinges on cost-cutting, international growth, and the possibility of a renewed offer.

Earnings

Global-E's Mixed Q1 Drives 10% Market Volatility

Investors are reacting to Global-E Online's mixed Q1 earnings and elevated FY26 outlook, with potential ripple effects on market indices and tech stocks. This event highlights regulatory and economic factors influencing finance, urging analysts to assess risk in earnings reports. Finance professionals should focus on how these results tie into broader market trends and investor sentiment.

Earnings

Figure Tech Beats Estimates by 15%, Boosting Stock

Figure Technology Solutions' Q1 earnings exceeded expectations, driving potential stock gains and influencing market trends. Investors should note the positive Q2 outlook amid broader economic uncertainties, highlighting opportunities in resilient tech stocks. This development underscores the importance of earnings data in shaping financial strategies.

How we covered this story

Every story in our finance coverage is assembled from multiple primary sources, cross-referenced for factual consistency, and scored along three independent dimensions: sentiment, operational impact, and source-cluster confidence. Single-source rumors and unverifiable claims do not pass our editorial gate. When a story shows "Verified by N sources" with N≥2, the development is independently corroborated; when N=1, we mark it explicitly so readers can weigh the signal accordingly.

Impact scoring uses a 1-10 scale weighted toward regulatory, financial, and operational consequence rather than coverage volume. A topic that runs in every outlet but moves no real decisions ranks lower than a niche regulatory filing that reshapes how operators in the finance space have to behave. Read our full methodology for the scoring rubric, our glossary for term definitions, and our trends index for the longitudinal view across the beat.

Signal on this pageWhat it tells you
Verified by N sourcesIndependent corroboration count. N≥2 is our confidence floor; N=1 is marked explicitly.
Impact score (1-10)Regulatory + financial + operational weight. 8+ signals an experienced-operator action item.
SentimentFive-tier classification trained on labeled finance-specific corpora.
TimelineWhere applicable, the related-events sequence that contextualizes today's development.